Mitotic phosphorylation activates hepatoma-derived growth factor as a mitogen

Allen D. Everett, Jun Yang, Monzur Rahman, Pratima Dulloor, David L. Brautigan

Research output: Contribution to journalArticle

Abstract

Background: Hepatoma-derived growth factor (HDGF) is a nuclear protein that is a mitogen for a wide variety of cells. Mass spectrometry based methods have identified HDGF as a phosphoprotein without validation or a functional consequence of this post-translational modification.Results: We found that HDGF in primary mouse aortic vascular smooth muscle cells (VSMC) was phosphorylated. Wild type HDGF was phosphorylated in asynchronous cells and substitution of S103, S165 and S202 to alanine each demonstrated a decrease in HDGF phosphorylation. A phospho-S103 HDGF specific antibody was developed and demonstrated mitosis-specific phosphorylation. HDGF-S103A was not mitogenic and FACS analysis demonstrated a G2/M arrest in HDGF-S103A expressing cells, whereas cells expressing HDGF-S103D showed cell cycle progression. Nocodazole arrest increased S103 phosphorylation from 1.6% to 29% (P = 0.037).Conclusions: Thus, HDGF is a phosphoprotein and phosphorylation of S103 is mitosis related and required for its function as a mitogen. We speculate that cell cycle regulated phosphorylation of HDGF may play an important role in vascular cell proliferation.

Original languageEnglish (US)
Article number15
JournalBMC Cell Biology
Volume12
DOIs
StatePublished - Apr 13 2011

ASJC Scopus subject areas

  • Cell Biology

Fingerprint Dive into the research topics of 'Mitotic phosphorylation activates hepatoma-derived growth factor as a mitogen'. Together they form a unique fingerprint.

  • Cite this